NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Technology and Digital Health > Machine learning system developed to identify deteriorating patients in hospital

Machine learning system developed to identify deteriorating patients in hospital

5 February 2021 · Listed under Technology and Digital Health

Researchers in Oxford have developed a machine learning algorithm that could significantly improve clinicians’ ability to identify hospitalised patients whose condition is deteriorating to the extent that they need intensive care.

Photo by Daan Stevens on Unsplash

The HAVEN system was developed as part of a collaboration between the University of Oxford’s Institute of Biomedical Engineering and the Nuffield Department of Clinical Neurosciences, with support from the NIHR Oxford Biomedical Research Centre.

The findings of the study have been published in the American Journal of Respiratory and Critical Care Medicine.

“The HAVEN machine learning algorithm, using electronic patient data collected routinely by most NHS hospitals, has the potential to substantially improve our ability to detect patients who require ICU, and those for whom a timely intervention is likely to change their outcome, so enhancing the National Early Warning Score (NEWS) system currently in use across the health service,” said Prof Peter Watkinson, Associate Professor of Intensive Care Medicine at the University’s Nuffield Department of Clinical Neurosciences.

The HAVEN (Hospital-wide Alerting Via Electronic Noticeboard) system combines patients’ vital signs – such as blood pressure, heart rate and temperature – with their blood test results, comorbidities and frailty into a single risk score. The HAVEN score gives a more precise indication of which patients are deteriorating when compared with previously published scores.

Every year, more than 60,000 patients deteriorate on UK hospital wards to the extent they require admission to an ICU.

Over the past 20 years, health care systems worldwide have implemented alerting systems to improve detection of patients at risk of deterioration. Most are based on abnormalities in patients’ vital signs, usually by combining them into an early warning score. Clinicians are alerted when the EWS rises above a given threshold.

“Late recognition of patient deterioration in hospital is associated with worse outcomes, including higher mortality. Despite the widespread introduction of early warning score systems, which are based on vital signs, deterioration still goes unrecognised,” Prof Watkinson explained.

“The HAVEN system we have developed and validated was able to detect nearly twice as many patients who suffered a cardiac arrest or needed intensive care up to 48 hours in advance, than the next best system.”

As well as the Oxford BRC, this independent research was funded by the Health Innovation Challenge Fund, a funding partnership between the Department of Health and Wellcome Trust.

← Using AI to improve the quality of endoscopy videos
Oxford academics named NIHR Senior Investigators →

News

  • Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination 24 May 2022
  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre